You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Aripiprazole versus placebo for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2011
|
| DOI | 10.1002/14651858.cd006622.pub2 |
| Pubmed ID | |
| Authors |
Ravindra B Belgamwar, Hany George G El‐Sayeh |
| Abstract |
First generation 'typical' antipsychotics such as chlorpromazine and haloperidol have been the mainstay of treatment up until the introduction of the second generation 'atypical' antipsychotics such as risperidone and olanzapine. Typical and atypical antipsychotics do provide a treatment response for most people with schizophrenia, whether a reduction in psychotic episodes or a lessening in the severity of their illness. However, a proportion of people still do not respond adequately to antipsychotic medication. Additionally, atypical and especially typical antipsychotics are associated with serious adverse effects, which can often compromise compliance with medication and therefore increase the incidences of relapse. In this review we examine the effects of aripiprazole compared with placebo. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 207 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 34 | 16% |
| Student > Bachelor | 31 | 15% |
| Researcher | 23 | 11% |
| Student > Ph. D. Student | 16 | 8% |
| Student > Doctoral Student | 13 | 6% |
| Other | 32 | 15% |
| Unknown | 61 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 69 | 33% |
| Psychology | 20 | 10% |
| Nursing and Health Professions | 16 | 8% |
| Neuroscience | 8 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Other | 23 | 11% |
| Unknown | 67 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2020.
All research outputs
#7,387,249
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,415
of 11,842 outputs
Outputs of similar age
#39,728
of 131,750 outputs
Outputs of similar age from Cochrane database of systematic reviews
#66
of 108 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 131,750 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.